These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 102267)

  • 1. Thyroid-stimulating hormone and prolactin levels in breast cancer.
    Aldinger KA; Schultz PN; Blumenschein GR; Samaan NA
    Arch Intern Med; 1978 Nov; 138(11):1638-41. PubMed ID: 102267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hyperthyroidism and subjects hyperresponding to thyrotropin. Importance of simultaneous thyrotropin and prolactin determination following administration of thyroid-releasing hormone].
    Schlienger JL; De Laharpe F; Reville P; Stephan F
    Sem Hop; 1980 May 8-15; 56(17-18):827-31. PubMed ID: 6248964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of thyrotropin, prolactin, growth hormone, triiodothyronine and thyroxine after oral administration of thyrotropin releasing hormone in hypothyroid and hyperthyroid patients.
    Nedvídková J; Felt V
    Endokrinologie; 1976; 68(2):175-82. PubMed ID: 827434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between thyroid-pituitary function and response to therapy in patients with recurrent breast cancer.
    Yokoe T; Iino Y; Takei H; Horiguchi J; Koibuchi Y; Maemura M; Ohwada S; Morishita Y
    Anticancer Res; 1996; 16(4A):2069-72. PubMed ID: 8712744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repetitive administration of thyrotropin-releasing hormone results in small elevations of serum thyroid hormones and in marked inhibition of thyrotropin response.
    Snyder PJ; Utiger RD
    J Clin Invest; 1973 Sep; 52(9):2305-12. PubMed ID: 4199417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hypothalamo-hypophyseal-thyroid axis in recruits and soldiers with male hypogonadism].
    Tomov T; Ankov V
    Vutr Boles; 1980; 19(5):53-61. PubMed ID: 6777988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human prolactin and thyrotropin concentrations in the serums of normal and hypopituitary children before and after the administration of synthetic thyrotropin-releasing hormone.
    Foley TP; Jacobs LS; Hoffman W; Daughaday WH; Blizzard RM
    J Clin Invest; 1972 Aug; 51(8):2143-50. PubMed ID: 4626583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mastopathy and breast cancer: is there a typical hormone profile?].
    Völker W; Leipert KP; Gehrlings H; Stauch G; von zur Mühlen A; Schneider J
    Geburtshilfe Frauenheilkd; 1986 May; 46(5):284-9. PubMed ID: 3087811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fibrocystic disease of breast and pituitary-thyroid axis function].
    Zych F; Mizia-Stec K; Mucha Z; Zych-Twardowska E
    Pol Merkur Lekarski; 1996 Oct; 1(4):227-8. PubMed ID: 9156929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum thyrotropin response to thyrotropin-releasing hormone and free thyroid hormone indices in patients with familiar thyroxine-binding globulin deficiency.
    Konno N
    Endocrinol Jpn; 1976 Aug; 23(4):313-7. PubMed ID: 828576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hypothalamic-pituitary-thyroid axis and melatonin in humans: possible interactions in the control of body temperature.
    Mazzoccoli G; Giuliani A; Carughi S; De Cata A; Puzzolante F; La Viola M; Urbano N; Perfetto F; Tarquini R
    Neuro Endocrinol Lett; 2004 Oct; 25(5):368-72. PubMed ID: 15580172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum concentrations of thyroxine, 3,5,3'-triiodothyronine, thyrotropin, and prolactin in dogs before and after thyrotropin-releasing hormone administration.
    Kaufman J; Olson PN; Reimers TJ; Allen TA; Soderberg SF; Nett TM; Wheeler SL; Wingfield WE
    Am J Vet Res; 1985 Feb; 46(2):486-92. PubMed ID: 3922262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid disease and function in breast cancer patients and non-hospitalized controls evaluated by determination of TSH, T3, rT3 and T4 levels in serum.
    Adami HO; Rimsten A; Thorén L; Vegelius J; Wide L
    Acta Chir Scand; 1978; 144(2):89-97. PubMed ID: 665106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid axis in patients with Cushing's syndrome.
    Duick DS; Wahner HW
    Arch Intern Med; 1979 Jul; 139(7):767-72. PubMed ID: 110278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in the nyctohemeral secretion of TSH and PRL in healthy euthyroid men.
    Dericks-Tan JS; Merz PG; Schrödter A; Taubert HD
    Exp Clin Endocrinol Diabetes; 1996; 104(2):145-50. PubMed ID: 8740938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disparity of thyrotropin (TSH) and prolactin responses to TSH-releasing hormone in obesity.
    Donders SH; Pieters GF; Heevel JG; Ross HA; Smals AG; Kloppenborg PW
    J Clin Endocrinol Metab; 1985 Jul; 61(1):56-9. PubMed ID: 3923032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Age-dependent changes of hypophysis-thyroid - regulation (author's transl)].
    Vosberg H; Wagner H; Böckel K; Hauss WH
    Aktuelle Gerontol; 1976 Jun; 6(6):279-84. PubMed ID: 14532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-response of prolactin and thyrotropin to N3im-methyl-thyrotropin releasing hormone in euthyroid men.
    Sowers JR; Hershman JM; Carlson HE; Pekary AE; Reed AW; Nair MG; Baugh CM
    J Clin Endocrinol Metab; 1976 Oct; 43(4):856-60. PubMed ID: 977724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypothalamus-hypophysis-thyroid axis function in healthy aging.
    Mazzoccoli G; Pazienza V; Piepoli A; Muscarella LA; Inglese M; De Cata A; Giuliani F; Tarquini R
    J Biol Regul Homeost Agents; 2010; 24(4):433-9. PubMed ID: 21122282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of obesity and drastic caloric restriction on serum prolactin and thyroid stimulating hormone.
    Wilson JH; Lamberts SW
    Int J Obes; 1981; 5(3):275-8. PubMed ID: 7275464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.